BioNTech SE American Depositary Share (BNTX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on BioNTech SE American Depositary Share (BNTX) is Neutral.

The composite score behind that read is -0.01, weighing +0.16 of bullish evidence against -0.25 bearish.

BioNTech SE American Depositary Share last closed at $96.96, +5.32% on the session.

Against the IVW growth benchmark the position is +4.52% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for BNTX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks BioNTech SE American Depositary Share in the 32nd percentile on return on equity, where 100 is best.

BioNTech SE American Depositary Share is classified under Health Care / Biotechnology, with a market capitalisation of $23.13B.

StockMap tracks BioNTech SE American Depositary Share as the 13th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite BioNTech SE American Depositary Share ranks 107th of 381 in the group, against a group median of -0.08.